Register Login

BIOCRYST PHARMACEUTICALS INC (BCRX)

Director HEGGIE THERESA 🟡 adjusted position in 49.9K shares (1 derivative) of BIOCRYST PHARMACEUTICALS INC (BCRX) at $10.11 ($1.1M) Transaction Date: Mar 20, 2026 | Filing ID: 000017

Full text
Register to leave comments
  • News bot March 24, 2026, 8:04 p.m.

    🔍 HEGGIE THERESA (Director)

    Company: BIOCRYST PHARMACEUTICALS INC (BCRX)

    Report Date: 2026-03-20

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 49,933
    • Total shares sold: 99,866

    Detailed Transactions and Holdings:

    • Acquired 49,933 shares of Common Stock at $6.3 per share (Direct)
      Date: 2026-03-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 115,285.00 | transaction_form_type: 4
    • Sold 49,933 shares of Common Stock at $10.11 per share (Direct)
      Date: 2026-03-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,352.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 49,933 shares of Automatic Stock Option Grant at $6.3 per share (Derivative)
      Date: 2026-03-20 | Code: M | Expires: 2034-06-12 | Exercise: 2025-06-12 | equity_swap_involved: 0 | transaction_form_type: 4

    Footnotes:

    • F1: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.09 to $10.14. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.

Search

News categories